ALAnna Lin

Anna Lin

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Anna Lin has a total of 24 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • 48. REVISITING THE NATIONAL NIGHTTIME CURRICULUM: HOW DO RESIDENTS REALLY WANT TO LEARN AT NIGHT?

    by Rebecca A. Ivancie, Anna Lin, H. Barrett Fromme, Nicole P. Black, Christine Skurkis, Jessica M. Allan, Jennifer Maniscalco, Rebecca Blankenburg


  • Open Access

    Magnetic Foreign Body Ingestion in Children: The Attractive Hazards

    by Anna Lin, Lawrence Chi Ngong Chan, Kam Lun Ellis Hon, Siu Yan Bess Tsui, Kristine Kit Yi Pang, Hon Ming Cheung, Alexander K. C. Leung

    Foreign body ingestions are frequent in the childhood population. Most foreign bodies are passed spontaneously through the gastrointestinal tract. However, on occasion, they can also be a rare cause of morbidity and even mortality, such as in the case of multiple magnetic foreign body ingestion, which can cause injury via magnetic attraction through bowel walls. We present two cases of multiple magnetic foreign body ingestion, which to our knowledge are the first ones reported in Hong Kong. One patient presented with shock and intestinal necrosis requiring extensive intestinal resection, whereas the other patient had no gastrointestinal injury but surgical removal was deemed necessary.


  • Excellent outcome of acute lymphoblastic leukaemia with TCF3‐PBX1 rearrangement in Hong Kong

    by Anna Lin, Frankie W.T. Cheng, Alan K.S. Chiang, Chung‐Wing Luk, Rever C.H. Li, Alvin S.C. Ling, Daniel K.L. Cheuk, Kai‐On Chang, Dennis Ku, Vincent Lee, et al.

    Objective: The aim of this study was to review clinical outcomes and prognosis of paediatric patients with acute lymphoblastic leukaemia (ALL) with TCF3‐PBX1 rearrangement.Patients: All children in Hong Kong diagnosed with ALL with TCF3‐PBX1 rearrangement over the past two decades were included.Methods: Six hundred and twenty‐four newly diagnosed patients with ALL from four consecutive studies were enrolled from 1997 to 2016. Patients carrying TCF3‐PBX1 rearrangement and patients at intermediate risk without the gene expression were compared for clinical characteristics, overall survival and event‐free survival (EFS).Results: The TCF3‐PBX1 rearrangement was detected in 30 of 624 patients (4.8%). Results were consistent across the consecutive clinical trials employed in the past two decades. Compared with 239 intermediate risk patients without TCF3‐PBX1 rearrangement, the 5‐year overall survival and EFS for patients with TCF3‐PBX1 rearrangement was superior, with both at 100% (P = 0.12 and P = 0.029).Conclusion: This population‐based study over the past 20 years demonstrated that patients with TCF3‐PBX1 rearrangement had favourable EFS compared with other intermediate risk patients treated with a similar chemotherapy backbone.